Global Alzheimer's diagnostic market — the international expansion of AD biomarker testing beyond North American and European academic centers toward broader global availability — reflects both the global burden of Alzheimer's disease and the commercial opportunity that aging populations in Asia-Pacific and other regions create, with the Alzheimer's Disease Diagnostic Market...